Literature DB >> 11751423

The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.

J B Wilson1, M A Johnson, A P Stuckert, K L Trueman, S May, P E Bryant, R E Meyn, A D D'Andrea, N J Jones.   

Abstract

Fanconi anemia (FA) is a human autosomal disorder characterized by cancer susceptibility and cellular sensitivity to DNA crosslinking agents such as mitomycin C and diepoxybutane. Six FA genes have been cloned including a gene designated XRCC9 (for X-ray Repair Cross Complementing), isolated using a mitomycin C-hypersensitive Chinese hamster cell mutant termed UV40, and subsequently found to be identical to FANCG. A nuclear complex containing the FANCA, FANCC, FANCE, FANCF and FANCG proteins is needed for the activation of a sixth FA protein FANCD2. When monoubiquitinated, the FANCD2 protein co-localizes with the breast cancer susceptibility protein BRCA1 in DNA damage induced foci. In this study, we have assigned NM3, a nitrogen mustard-hypersensitive Chinese hamster mutant to the same genetic complementation group as UV40. NM3, like human FA cell lines (but unlike UV40) exhibits a normal spontaneous level of sister chromatid exchange. We show that both NM3 and UV40 are also hypersensitive to other DNA crosslinking agents (including diepoxybutane and chlorambucil) and to non-crosslinking DNA damaging agents (including bleomycin, streptonigrin and EMS), and that all these sensitivities are all corrected upon transfection of the human FANCG/XRCC9 cDNA. Using immunoblotting, NM3 and UV40 were found not to express the active monoubiquitinated isoform of the FANCD2 protein, although expression of the FANCD-L isoform was restored in the FANCG cDNA transformants, correlating with the correction of mutagen-sensitivity. These data indicate that cellular resistance to these DNA damaging agents requires FANCG and that the FA gene pathway, via its activation of FANCD2 and that protein's subsequent interaction with BRCA1, is involved in maintaining genomic stability in response not only to DNA interstrand crosslinks but also a range of other DNA damages including DNA strand breaks. NM3 and other "FA-like" Chinese hamster mutants should provide an important resource for the study of these processes in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751423     DOI: 10.1093/carcin/22.12.1939

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

2.  Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.

Authors:  Kimiyo N Yamamoto; Shunsuke Kobayashi; Masataka Tsuda; Hitoshi Kurumizaka; Minoru Takata; Koichi Kono; Josef Jiricny; Shunichi Takeda; Kouji Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

3.  Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.

Authors:  Aleksandra M Gorniewska; Katarzyna Kluzek; Lidia Gackowska; Izabela Kubiszewska; Malgorzata Z Zdzienicka; Aneta Bialkowska
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

4.  Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Authors:  Philip S Rudland; Angela M Platt-Higgins; Lowri M Davies; Suzete de Silva Rudland; James B Wilson; Abdulaziz Aladwani; John H R Winstanley; Dong L Barraclough; Roger Barraclough; Christopher R West; Nigel J Jones
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.

Authors:  Richard D Kennedy; Clark C Chen; Patricia Stuckert; Elyse M Archila; Michelle A De la Vega; Lisa A Moreau; Akiko Shimamura; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2007-04-12       Impact factor: 14.808

6.  mRNA 3' tagging is induced by nonsense-mediated decay and promotes ribosome dissociation.

Authors:  Igor Y Morozov; Meriel G Jones; Peter D Gould; Victoria Crome; James B Wilson; Anthony J W Hall; Daniel J Rigden; Mark X Caddick
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

7.  Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.

Authors:  Kazuhiko Yamamoto; Masamichi Ishiai; Nobuko Matsushita; Hiroshi Arakawa; Jane E Lamerdin; Jean-Marie Buerstedde; Mitsune Tanimoto; Mine Harada; Larry H Thompson; Minoru Takata
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 8.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

9.  FANCG is phosphorylated at serines 383 and 387 during mitosis.

Authors:  Jun Mi; Fengyu Qiao; James B Wilson; Anthony A High; Melanie J Schroeder; Peter T Stukenberg; Amy Moss; Jeffrey Shabanowitz; Donald F Hunt; Nigel J Jones; Gary M Kupfer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions.

Authors:  Verena M Kuhnert; Lisa A Kachnic; Li Li; Martin Purschke; Liliana Gheorghiu; Richard Lee; Kathryn D Held; Henning Willers
Journal:  Int J Radiat Biol       Date:  2009-06       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.